본문으로
MMadical AI Use

Source record

Quantitative assist for immunohistochemistry scoring

공급사 보고공급사

이 언어의 본문은 아직 없어 영어로 보여 줍니다.

The source is PathAI’s company website, dated in this index as 1 February 2025, read as a vendor description of algorithms that estimate immunohistochemistry staining. Ibex is named as another vendor in the same class. The page is not an independent concordance study. No percentage agreement is copied, because those figures are assay-specific and easy to over-read.

Source date
2025년 2월 1일 · 연도 2025
Evidence label
공급사 보고
Source type
공급사

Citation

PathAI

PathAI. Company website, dated in this index as 1 February 2025. https://www.pathai.com/ Vendor description of pathology algorithms. Ibex is named only as another company offering quantitative immunohistochemistry assist. Not an independent assay study.

Key public facts

  • The cited page is a vendor website, not a peer-reviewed concordance study.
  • The workflow is an estimate of staining extent, such as Ki-67 or PD-L1, on a digitized slide that already has a clinical scoring scheme.
  • A pathologist checks the region and the number before the score enters the report.
  • The signed score remains a pathology result.
  • No concordance figure is copied. Vendor white papers stay vendor-reported until an independent study matches the assay in local use.
Original link

Opens the publisher page in a new tab.

Back to the case

교육과 시장 탐색용 항목. 의학 조언도 추천도 아닙니다.

후원

이 색인의 임상 독자에게 닿습니다.

후원 안내